Literature DB >> 25465392

Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.

Elena Karavaeva1, Robert J Harris, Kevin Leu, Maryam Shabihkhani, William H Yong, Whitney B Pope, Albert Lai, Phioanh L Nghiemphu, Linda M Liau, Wei Chen, Johannes Czernin, Timothy F Cloughesy, Benjamin M Ellingson.   

Abstract

PURPOSE: Diffusion magnetic resonance imaging (MRI) and 6-[(18)F]fluoro-L-dopa ([(18)F]FDOPA) positron emission tomography (PET) are used to interrogate malignant tumor microenvironment. It remains unclear whether there is a relationship between [(18)F]FDOPA uptake, diffusion MRI estimates of apparent diffusion coefficient (ADC), and mitotic activity in the context of recurrent malignant gliomas, where the tumor may be confounded by the effects of therapy. The purpose of the current study is to determine whether there is a correlation between these imaging techniques and mitotic activity in malignant gliomas. PROCEDURES: We retrospectively examined 29 patients with recurrent malignant gliomas who underwent structural MRI, diffusion MRI, and [(18)F]FDOPA PET prior to surgical resection. Qualitative associations were noted, and quantitative voxel-wise and median measurement correlations between [(18)F]FDOPA PET, ADC, and mitotic index were performed.
RESULTS: Areas of high [(18)F]FDOPA uptake exhibited low ADC and areas of hyperintensity T2/fluid-attenuated inversion recovery (FLAIR) with low [(18)F]FDOPA uptake exhibited high ADC. There was a significant inverse voxel-wise correlation between [(18)F]FDOPA and ADC for all patients. Median [(18)F]FDOPA uptake and median ADC also showed a significant inverse correlation. Median [(18)F]FDOPA uptake was positively correlated, and median ADC was inversely correlated with mitotic index from resected tumor tissue.
CONCLUSIONS: A significant association may exist between [(18)F]FDOPA uptake, diffusion MRI, and mitotic activity in recurrent malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25465392     DOI: 10.1007/s11307-014-0807-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  38 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Maximum-likelihood expectation-maximization reconstruction of sinograms with arbitrary noise distribution using NEC-transformations.

Authors:  J Nuyts; C Michel; P Dupont
Journal:  IEEE Trans Med Imaging       Date:  2001-05       Impact factor: 10.048

3.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

4.  18F-FET PET differentiation of ring-enhancing brain lesions.

Authors:  Frank W Floeth; Dirk Pauleit; Michael Sabel; Guido Reifenberger; Gabriele Stoffels; Walter Stummer; Frank Rommel; Kurt Hamacher; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

5.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence.

Authors:  Chiaki Asao; Yukunori Korogi; Mika Kitajima; Toshinori Hirai; Yuji Baba; Keishi Makino; Masato Kochi; Shoji Morishita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

6.  The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms.

Authors:  Richard A Prayson
Journal:  Adv Anat Pathol       Date:  2005-05       Impact factor: 3.875

Review 7.  Diffusion imaging for evaluation of tumor therapies in preclinical animal models.

Authors:  B A Moffat; D E Hall; J Stojanovska; P J McConville; J B Moody; T L Chenevert; A Rehemtulla; B D Ross
Journal:  MAGMA       Date:  2004-12-01       Impact factor: 2.310

8.  Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity.

Authors:  T Kato; J Shinoda; N Oka; K Miwa; N Nakayama; H Yano; T Maruyama; Y Muragaki; T Iwama
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-07       Impact factor: 3.825

9.  11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Authors:  Sungeun Kim; June-Key Chung; So-Hyang Im; Jae Min Jeong; Dong Soo Lee; Dong Gyu Kim; Hee Won Jung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-10       Impact factor: 9.236

10.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.

Authors:  T L Chenevert; P E McKeever; B D Ross
Journal:  Clin Cancer Res       Date:  1997-09       Impact factor: 12.531

View more
  18 in total

1.  Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma.

Authors:  Ararat Chakhoyan; Davis C Woodworth; Robert J Harris; Albert Lai; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2018-05-31       Impact factor: 4.130

2.  Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

Authors:  Giovanni Morana; Arnoldo Piccardo; Domenico Tortora; Matteo Puntoni; Mariasavina Severino; Paolo Nozza; Marcello Ravegnani; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Manlio Cabria; Antonio Verrico; Claudia Milanaccio; Andrea Rossi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 9.236

3.  Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.

Authors:  Joseph P Antonios; Horacio Soto; Richard G Everson; Diana L Moughon; Anthony C Wang; Joey Orpilla; Caius Radu; Benjamin M Ellingson; Jason T Lee; Timothy Cloughesy; Michael E Phelps; Johannes Czernin; Linda M Liau; Robert M Prins
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

4.  Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.

Authors:  Hiroyuki Tatekawa; Akifumi Hagiwara; Hiroyuki Uetani; Jingwen Yao; Talia C Oughourlian; Shadfar Bahri; Chencai Wang; Catalina Raymond; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope; Noriko Salamon; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2020-09-14       Impact factor: 4.130

5.  Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.

Authors:  Flóra John; Edit Bosnyák; Natasha L Robinette; Alit J Amit-Yousif; Geoffrey R Barger; Keval D Shah; Sharon K Michelhaugh; Neil V Klinger; Sandeep Mittal; Csaba Juhász
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

6.  Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement.

Authors:  Nicholas Cho; Chencai Wang; Catalina Raymond; Tania Kaprealian; Matthew Ji; Noriko Salamon; Whitney B Pope; Phioanh L Nghiemphu; Albert Lai; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2020-04-01       Impact factor: 4.130

Review 7.  Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Timothy F Cloughesy
Journal:  Cancer J       Date:  2021 Sep-Oct 01       Impact factor: 3.360

Review 8.  Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.

Authors:  Lisbeth Marner; Otto M Henriksen; Michael Lundemann; Vibeke Andrée Larsen; Ian Law
Journal:  Clin Transl Imaging       Date:  2016-11-18

9.  18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.

Authors:  Karen Gauvain; Maria Rosana Ponisio; Amy Barone; Michael Grimaldi; Ephraim Parent; Hayden Leeds; Manu Goyal; Joshua Rubin; Jonathan McConathy
Journal:  Neurooncol Pract       Date:  2017-05-25

10.  Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma.

Authors:  Warren Chang; Whitney B Pope; Robert J Harris; Anthony J Hardy; Kevin Leu; Reema R Mody; Phioanh L Nghiemphu; Albert Lai; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Tomography       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.